Flora Growth Corp
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
ZSTK$2.53-5.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Loss and Comprehensive Loss
(in thousands of United States dollars, except per share amounts which are in thousands of shares)
| For the year endedDecember 31, 2023 | For the year endedDecember 31, 2022 | |
|---|---|---|
| Revenue | $76,071 | $33,401 |
| Cost of sales | 58,333 | 20,150 |
| Gross profit | 17,738 | 13,251 |
| Operating expenses | ||
| Consulting and management fees | 11,876 | 9,232 |
| Professional fees | 2,301 | 3,884 |
| General and administrative | 1,646 | 3,287 |
| Promotion and communication | 4,710 | 8,033 |
| Travel expenses | 413 | 930 |
| Share based compensation | 1,591 | 3,404 |
| Research and development | 62 | 388 |
| Operating lease expense | 1,211 | 937 |
| Depreciation and amortization | 2,335 | 2,144 |
| Bad debt expense | 236 | 941 |
| Goodwill impairment | 23,372 | 25,072 |
| Other asset impairments | 16,135 | 709 |
| Other expenses (income), net | 2,204 | 1,511 |
| Total operating expenses | 68,092 | 60,472 |
| Operating loss | (50,354) | (47,221) |
| Interest expense (income) | 92 | (29) |
| Foreign exchange (income) loss | (158) | 323 |
| Unrealized (gain) loss from changes in fair value | (1,991) | 593 |
| Net loss before income taxes and discontinued operations | (48,297) | (48,108) |
| Income tax benefit | (1,628) | (1,405) |
| Net loss from continuing operations | (46,669) | (46,703) |
| Loss from discontinued operations, net of taxes | (9,678) | (5,926) |
| Net loss for the period | (56,347) | (52,629) |
| Net income (loss) attributable to noncontrolling interest | 689 | (214) |
| Net loss attributable to Flora Growth Corp | $(57,036) | $(52,415) |
| Basic loss per share from continuing operations | $(6.34) | $(12.19) |
| Diluted loss per share from continuing operations | $(6.34) | $(12.19) |
| Basic loss per share attributable to Flora Growth Corp. | $(7.75) | $(13.68) |
| Diluted loss per share attributable to Flora Growth Corp. | $(7.75) | $(13.68) |
| Weighted average number of common shares outstanding - basic | 7,356 | 3,832 |
| Weighted average number of common shares outstanding - diluted | 7,356 | 3,832 |
| Comprehensive loss: | ||
| Net loss | $(56,347) | $(52,629) |
| Foreign currency translation, net of income taxes of $nil ($nil in 2022) | (2,592) | 1,624 |
| Comprehensive loss for the period | (53,755) | (54,253) |
| Comprehensive income (loss) attributable to noncontrolling interests | 689 | (214) |
| Comprehensive loss attributable to Flora Growth Corp. | $(54,444) | $(54,039) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.